期刊文献+

疏肝健脾法联合阿托伐他汀治疗乳腺癌合并代谢综合征患者的疗效观察 被引量:2

Effective observation on treating breast cancer with metabolic syndromeby the Shugan Jianpi therapy plus atorvastatin
下载PDF
导出
摘要 目的:观察疏肝健脾法联合阿托伐他汀治疗乳腺癌合并代谢综合征患者的疗效。方法:将60例符合诊断标准的乳腺癌术后、合并有代谢综合征的患者随机分为试验组30例及对照组30例。两组均服用阿托伐他汀治疗,试验组在化疗基础上予疏肝健脾组方中药治疗。结果:试验组治疗后腰围、BMI明显下降(P<0.05);两组TC、TG、HDL-C、LDL-C等指标分别比治疗前明显下降(P<0.05);试验组TG、LDL-C与对照组比较,差异有统计学意义(P<0.05)。两组患者自身治疗前后生活质量均有改善,治疗组较对照组改善更好,差异有统计学意义(P<0.05)。结论:疏肝健脾法联合阿托伐他汀治疗乳腺癌合并代谢综合征患者,可降低患者血糖、血脂、体重指数,提高患者生活质量。 Objective:To observe the effect of Shugan Jianpi therapy combined with atorvastatin on breast cancer with metabolic syndrome patients.Methods:60post-operative breast cancer patients with metabolic syndrome were randomly divided into two groups,with30cases in the experimental group and30cases in the control group.Both the groups were given atorvastatin treatment,in addition,the experimental group received extra Shugan Jianpi prescription.Results:After treatment,compared with the control group,the waist circumference and BMI outcomes of the patients in experimental group decreased significantly(P<0.05).The TC,TG,HDL-C,LDL-C and other indicators were significantly decreased than those before treatment in two groups(P<0.05).Compared with the control group,TG,LDL-C were statistically significant decreased in the experimental group(P<0.05).The quality of life in two groups were improved after treatment.Conclusion:The Shugan Jianpi therapy plus atorvastatin could reduce the blood glucose,blood lipid,body mass index in the treatment of breast cancer patients with metabolic syndrome.
作者 顾文静
出处 《中医临床研究》 2017年第9期115-117,共3页 Clinical Journal Of Chinese Medicine
关键词 疏肝健脾法 乳腺癌 代谢综合征 Shugan Jianpi therapy Breast cancer Metabolic syndrome
  • 相关文献

参考文献3

二级参考文献27

  • 1英子伟,张斌.肥胖与乳腺癌临床生物学特性[J].实用肿瘤学杂志,1996,10(2):38-39. 被引量:3
  • 2李涛,牛丽娟,李曼,刘殿武.居室内氡与白血病患病关系的Meta分析[J].临床荟萃,2007,22(11):797-798. 被引量:5
  • 3张宏艳,刘端祺,范萍,黄其敏,侯新燕,彭雁,矫健,吕楠.乳腺癌普查初步报道及资料分析[J].解放军医学杂志,2007,32(6):654-654. 被引量:49
  • 4Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world- wide definition. A Consensus Statement from the InternationalDiabetes Federation [ J ] . Diabet Med, 2006, 23 ( 5 ) : 469-480. 被引量:1
  • 5Furberg AS, Veierod MB, Wilsgaard T, et al. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk [ J ]. J Natl Cancer Inst, 2004, 96 ( 15 ) : 1152-1160. 被引量:1
  • 6Soler M, Chatenoud L, Negri E, et al. Hypertension and hormone- related neoplasms in women [ J ] . Hypertension, 1999, 34 ( 2 ) : 320-325. 被引量:1
  • 7Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer : a review of the current evidence [ J ] . Am J Clin Nutr, 2007, 86 ( 3 ) : s823-s835. 被引量:1
  • 8Chen TH, Chiu YH, Luh DL, et al. Community-based multiple screening model : design, implementation, and analysis of 42, 387 parlicipams [ J ] . Cancer, 2004, 1130 ( 8 ) : 1734-1743. 被引量:1
  • 9Osaki Y, Taniguehi S, Tahara A, et al. Metabolic syndrome and incidence of liver and breast cancers in Japan [ J ] . Cancer Epidemiol, 2012, 36 ( 2 ) : 141-147. 被引量:1
  • 10Noh HM, Song YM, Fark JH, et al. Metabolic factors and breast Cancer risk in Korean women [ J ] . Cancer Causes Control, 2013, 24 ( 6 ) : 1061-1068. 被引量:1

共引文献9

同被引文献47

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部